Lv71
3290 积分 2023-11-22 加入
A versatile antibody capture system drives specific in vivo delivery of mRNA-loaded lipid nanoparticles
2小时前
待确认
Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects
2小时前
已完结
CAR T cells produced in vivo to treat cardiac injury
3小时前
已完结
CAR Treg: A new approach in the treatment of autoimmune diseases
12小时前
已完结
CAR T-cell therapy in autoimmune diseases
12小时前
已完结
Engineering CAR-T therapies for autoimmune disease and beyond
13小时前
已完结
Critical Conditions for Studying Interleukin‐11 Signaling In Vitro and Avoiding Experimental Artefacts
1个月前
已完结
An Update on JAK Inhibitors
1个月前
已完结
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
2个月前
已完结
Efruxifermin, an investigational treatment for fibrotic or cirrhotic nonalcoholic steatohepatitis (NASH)
2个月前
已完结
皖公网安备34019202002308
